Biomarkers involved in the neoadjuvant therapy response in triple-negative and Her2+ subtypes breast cancer.

e12098Background: Neoadjuvant systemic therapy for breast cancer is used increasingly for patients with breast cancer. One of the more compelling theoretical arguments for primary systemic therapy ...